The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis
Abstract
INTRODUCTION: Chronic osteomyelitis, or bone infection, is a major worldwide cause of morbidity and mortality, as it is exceptionally hard to treat due to patient and pathogen-associated factors. Successful treatment requires surgical debridement together with long-term, high antibiotic concentrations that are best achieved by local delivery devices, either made of degradable or non-degradable materials. AREAS COVERED: Non-degradable delivery devices are frequently constituted by polymethylmethacrylate-based carriers. Drawbacks are the need to remove the carrier (as the carrier itself may provide a substratum for bacterial colonization), inefficient release kinetics and incompatibility with certain antibiotics. These drawbacks have led to the quest for degradable alternatives, but also devices made of biodegradable calcium sulphate, collagen sponges, calcium phosphate or polylactic acids have their specific disadvantages. EXPERT OPINION: Antibiotic treatment of osteomyelitis with the current degradable and non-degradable delivery devices is effective in the majority of cases. Degradable carriers have an advantage over non-degradable carriers that they do not require surgical removal. Synthetic poly(trimethylene carbonate) may be preferred in the future over currently approved lactic/glycolic acids, because it does not yield acidic degradation products. Moreover, degradable poly(trimethylene carbonate) yields a zero-order release kinetics that may not stimulate development of antibiotic-resistant bacterial strains due to the absence of long-term, low-concentration tail-release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biomedical applications of biodegradable polymers
Ulery, B. D., Nair, L. S., & Laurencin, C. T. (2011) · Journal of Polymer Science Part B: Polymer Physics · doi:10.1002/polb.22259 · Cited by 2,206
Physiology and Antibiotic Susceptibility of Staphylococcus aureus Small Colony Variants
Baumert, N., von Eiff, C., Schaaff, F., Peters, G., Proctor, R. A., & Sahl, H.-G. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469507 · Cited by 130
Release of gentamicin from acrylic bone cement
Bunetel, L., Segui, A., Cormier, M., Percheron, E., & Langlais, F. (1989) · Clinical Pharmacokinetics · doi:10.2165/00003088-198917040-00006 · Cited by 123
van de Belt, H., Neut, D., van Horn, J. R., van der Mei, H. C., Schenk, W., & Busscher, H. J. (1999) · Nature Medicine · doi:10.1038/7330 · Cited by 55
Self-citation
Cited by
A Review of Biodegradable Natural Polymer-Based Nanoparticles for Drug Delivery Applications
Idrees, H., Zaidi, S. Z. J., Sabir, A., Khan, R. U., Zhang, X., & Hassan, S.-U. (2020) · Nanomaterials · doi:10.3390/nano10101970 · Cited by 419
Nanoparticle-based local antimicrobial drug delivery
Gao, W., Chen, Y., Zhang, Y., Zhang, Q., & Zhang, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.015 · Cited by 396
Antifouling and antimicrobial biomaterials: an overview
Francolini, I., Vuotto, C., Piozzi, A., & Donelli, G. (2017) · APMIS · doi:10.1111/apm.12675 · Cited by 322
Li, Y., Liu, L., Wan, P., Zhai, Z., Mao, Z., Ouyang, Z., Yu, D., Sun, Q., Tan, L., Ren, L., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.08.031 · Cited by 286
Combating Implant Infections: Shifting Focus from Bacteria to Host
Amin Yavari, S., Castenmiller, S. M., van Strijp, J. A. G., & Croes, M. (2020) · Advanced Materials · doi:10.1002/adma.202002962 · Cited by 257
Metadata
- Authors
- Kluin, O. S., van der Mei, H. C., Busscher, H. J., & Neut, D.
- Venue
- Expert Opinion on Drug Delivery
- Publisher
- Informa UK Limited
- Published
- 2013-01-06
- Volume
- 10
- Issue
- 3
- Pages
- 341-351
- ISSN
- 1742-5247 (ISSN-L)
- 1744-7593
- OpenAlex
- W2121388120
- Cited by
- 171
- References
- 4
- FWCI
- 14.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. https://app.cochat.ai/papers/10.1517/17425247.2013.751371
- The paper
- Kluin, O. S., van der Mei, H. C., Busscher, H. J., & Neut, D. (2013). Biodegradable vs non-biodegradable antibiotic delivery devices in the treatment of osteomyelitis. Expert Opinion on Drug Delivery. https://doi.org/10.1517/17425247.2013.751371
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.